ALEXANDRIA REAL EST. EQU./ US0152711091 /
07.11.2024 13:41:17 | Изменение +4.20 | Объем сделки | Бид14:53:55 | Предложение14:53:55 | Рыночная капитализация | Дивидендная доходность | Коэффициент Цена/Доход |
---|---|---|---|---|---|---|---|
106.25EUR | +4.12% | 23 Оборот: 2,443.75 |
103.90Величина цены спроса: 25 | 105.95Величина цены предложения: 24 | 18.4 млрдEUR | - | - |
GlobeNewswire
20.10.2023
SHARC Energy at Forefront of Alexandria’s Sustainable Mega Campus Initiative
GlobeNewswire
21.09.2023
Atreca Announces Agreement to Terminate Lease and Departure of Chief Financial Officer Herb Cross
GlobeNewswire
23.02.2022
Intellia Therapeutics Enters Lease Agreement to Build Manufacturing Facility for its CRISPR-based Th...
GlobeNewswire
21.10.2021
Orange Grove Bio, AlleyCorp and Alexandria Venture Investments Establish Partnership with Albert Ein...
GlobeNewswire
21.09.2021
Adaptive Biotechnologies Announces Grand Opening of State-of-the-Art Headquarters and Expands Footpr...
GlobeNewswire
13.05.2021
TCR² Therapeutics Reports First Quarter 2021 Financial Results and Provides Corporate Update
GlobeNewswire
29.03.2021
TCR² Therapeutics Establishes Commercial-Scale Cell Therapy Manufacturing Facility
GlobeNewswire
24.02.2021
Life Science Cares and Biogen Foundation Help Launch Food For Free’s Just Eats Program
GlobeNewswire
12.08.2020
Beam Therapeutics Announces First Development Candidates for Sickle Cell Disease and Reports Second ...
GlobeNewswire
14.11.2019
Sarepta and StrideBio Announce Multi-target Strategic Collaboration to Advance Novel Gene Therapies
- Первая страница
- Назад
- 1
- 2
- Следующий
- Последняя страница